Faster, Smarter, Better: How Analytics Are Boosting Clinical Data Quality

The life science industry has been exploring new ways to harness data and analytics for conducting clinical studies. These efforts have resulted in an explosion of new data coming into the trial for analysis. Tufts estimates that tens of millions of data points pass through Phase 3 trials, a 10x increase from a decade ago. And, in the case of wearable devices and sensors, there could be billions of data points. While the influx of data is great for researchers, it still requires the team to review, clean, and monitor to draw reliable conclusions that influence trial outcomes.

The question then arises: How are organizations keeping up with managing data quality on this kind of scale? Hear the answer to that questions and gain insight from the Director of Clinical Data, Central Monitoring, and Oversight at Moderna Heidi McIntyre, Senior Director of RBQM R&D at Medidata Olgica Klindworth, and Senior Director of Clinical Operations Portfolio at Medidata Ken Hamill on clinical trials design and delivery.